Company Description
Meihua International Medical Technologies Co., Ltd. engages in the manufacture, sells, and marketing of medical consumables in the People's Republic of China.
The company offers class I, II, and III disposable medical devices. Its products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles, as well as electronic pumps.
The company also distributes disposable medical devices sourced from other manufacturers to customers in China.
In addition, it offers COVID-19 products comprising disposable medical masks. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies.
It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China.
Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.
| Country | China |
| Founded | 1990 |
| IPO Date | Feb 16, 2022 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 626 |
| CEO | Wang Xin |
Contact Details
Address: 88 Tongda Road, Touqiao Town, Guangling District Yangzhou, F4 225000 China | |
| Phone | (86) 0514-89800199 |
| Website | meihuamed.com |
Stock Details
| Ticker Symbol | MHUA |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001835615 |
| CUSIP Number | G5966G108 |
| ISIN Number | KYG5966G1082 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Wang Xin | Chief Executive Officer and Director |
| Lianzhang Zhao | Chief Financial Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 3, 2024 | 6-K | Report of foreign issuer |
| Mar 5, 2024 | 6-K | Report of foreign issuer |
| Feb 27, 2024 | EFFECT | Notice of Effectiveness |
| Feb 27, 2024 | 424B3 | Prospectus |
| Feb 23, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Feb 21, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Feb 13, 2024 | UPLOAD | Filing |
| Feb 6, 2024 | F-1 | Registration statement for certain foreign private issuers |
| Jan 8, 2024 | D | Notice of Exempt Offering of Securities |
| Jan 2, 2024 | 6-K | Report of foreign issuer |